First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
Titel:
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
Auteur:
Patnaik, A. Appleman, L.J. Tolcher, A.W. Papadopoulos, K.P. Beeram, M. Rasco, D.W. Weiss, G.J. Sachdev, J.C. Chadha, M. Fulk, M. Ejadi, S. Mountz, J.M. Lotze, M.T. Toledo, F.G.S. Chu, E. Jeffers, M. Peña, C. Xia, C. Reif, S. Genvresse, I. Ramanathan, R.K.